Review





Similar Products

94
InvivoGen hek blue reporter assay il23
Hek Blue Reporter Assay Il23, supplied by InvivoGen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il23/HEK-Blue+IL-23+Cells/pm41944084-322-10-16
Average 94 stars, based on 1 article reviews
hek blue reporter assay il23 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
MedChemExpress recombinant il23
Recombinant Il23, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il23/IL-23+alpha%2C+Human/pm41576569-71-0-5
Average 94 stars, based on 1 article reviews
recombinant il23 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

95
R&D Systems human il23
Human Il23, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il23/Recombinant+Human+IL-23+Protein/pmc13126671-306-26-29
Average 95 stars, based on 1 article reviews
human il23 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

96
InvivoGen hek-blue il-23 cells
Hek Blue Il 23 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il23/HEK-Blue+IL-23+Cells/custom%40hkb-il23%4041944084
Average 96 stars, based on 1 article reviews
hek-blue il-23 cells - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

94
OriGene wt human il23r

Wt Human Il23r, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il23/IL23+Receptor+(IL23R)+(NM_144701)+Human+Tagged+ORF+Clone/bio_rxiv__64898__2026__03__23__713554-217-3-6
Average 94 stars, based on 1 article reviews
wt human il23r - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

95
R&D Systems mouse il23

Mouse Il23, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il23/Recombinant+Mouse+IL-23+Protein/pm41712290-99-25-27
Average 95 stars, based on 1 article reviews
mouse il23 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

94
InvivoGen hek

Hek, supplied by InvivoGen, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il23/HEK-Blue+IL-23+Cells/pm41611152-126-0-6
Average 94 stars, based on 1 article reviews
hek - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

97
InvivoGen treatment with il23

Treatment With Il23, supplied by InvivoGen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/il23/QUANTI-Blue+Solution/pm41611152-130-41-58
Average 97 stars, based on 1 article reviews
treatment with il23 - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

Image Search Results


Journal: bioRxiv

Article Title: Homozygosity for rare or common hypomorphic IL23R variants confers a predisposition to tuberculosis in humans

doi: 10.64898/2026.03.23.713554

Figure Lengend Snippet:

Article Snippet: Plasmids containing the WT human IL23R (Origene #RG211477) ORF were obtained, the tag was removed, and the variants studied here were generated by site-directed mutagenesis with specific primers and CloneAmp HiFi PCR premix (Takara).

Techniques: Variant Assay

(A) STAT3 activity induced in response to IL-23 (10 ng/mL) by the IL23R variants used for the transient transfection of HEK293T cells, assessed with the luciferase assay. White dots represent negative controls (NT, not transfected and EV, empty vector); green dots, WT condition; red dots, LOF variant; gray dots, homozygous variants from the general population. (B) Western blot of pSTAT3 after stimulation with IL-23 (1 ng/mL) or IFN-α (1 ng/mL) in HEK293T cells transiently transfected with IL23R variants. The graph shows pSTAT3/STAT3 band density as a percentage of that in stimulated WT conditions. At least two independent experiments were performed. (C) CADD /MAF graph for the homozygous IL23R LOF variants previously described (red triangle) in the MSMD cohort, and the missense variants (dots) from the general population and our in-house cohort. The four hypomorphic variants are presented in different colors, whereas the isomorphic variants are in shown in gray. MSC, mutation significance cutoff with a 99% confidence interval. CADD, Combined annotation-dependent depletion. (D) Localization of coding and non-coding LOF (red) or hypomorphic (orange, yellow, blue and violet) IL23R variants across IL-23R protein domains.

Journal: bioRxiv

Article Title: Homozygosity for rare or common hypomorphic IL23R variants confers a predisposition to tuberculosis in humans

doi: 10.64898/2026.03.23.713554

Figure Lengend Snippet: (A) STAT3 activity induced in response to IL-23 (10 ng/mL) by the IL23R variants used for the transient transfection of HEK293T cells, assessed with the luciferase assay. White dots represent negative controls (NT, not transfected and EV, empty vector); green dots, WT condition; red dots, LOF variant; gray dots, homozygous variants from the general population. (B) Western blot of pSTAT3 after stimulation with IL-23 (1 ng/mL) or IFN-α (1 ng/mL) in HEK293T cells transiently transfected with IL23R variants. The graph shows pSTAT3/STAT3 band density as a percentage of that in stimulated WT conditions. At least two independent experiments were performed. (C) CADD /MAF graph for the homozygous IL23R LOF variants previously described (red triangle) in the MSMD cohort, and the missense variants (dots) from the general population and our in-house cohort. The four hypomorphic variants are presented in different colors, whereas the isomorphic variants are in shown in gray. MSC, mutation significance cutoff with a 99% confidence interval. CADD, Combined annotation-dependent depletion. (D) Localization of coding and non-coding LOF (red) or hypomorphic (orange, yellow, blue and violet) IL23R variants across IL-23R protein domains.

Article Snippet: Plasmids containing the WT human IL23R (Origene #RG211477) ORF were obtained, the tag was removed, and the variants studied here were generated by site-directed mutagenesis with specific primers and CloneAmp HiFi PCR premix (Takara).

Techniques: Activity Assay, Transfection, Luciferase, Plasmid Preparation, Variant Assay, Western Blot, Mutagenesis

(A) Emitted luminescence measured in the presence of the NanoLuc inhibitor is expressed as a percentage of that measured in the absence of the inhibitor (100%), in HEK293T cells transiently transfected with N-terminal NanoLuciferase-tagged versions of the wildtype or variants of the IL-23 receptor (NLuc IL-23R, NLuc IL-23R R381Q, NLuc IL-23R G300V, NLuc IL-23R G149R, NLuc IL-23R L372F or NLuc IL-23R C115Y) and IL-12Rβ1 (4:1 ratio). The data shown are the mean ± SEM from 5-7 independent experiments conducted in triplicate wells. Statistical significance was determined in a paired t-test (*** P <0.001, * P <0.5). Data for NLuc IL-23R C115Y were obtained in a previous study. (B) HEK293T cells transiently transfected as described in A) were imaged with an Olympus LuminoView 200 wide-field luminescence microscope. Representative luminescence images show the signal originating from the N-terminal NLuc tag of each IL-23R variant following the addition of furimazine (final dilution 1:400). Data from three independent experiments are shown. The scale bar represents 50 μm. Luminescence images were acquired with a 60x NA1.42 oil immersion objective, a 0.5x tube lens, and a C9100-23B IMAGE EMX2 camera (Hamamatsu, Japan), with an exposure time of 20 s (gain of 25). (C) HEK293T cells transiently transfected as in A) were treated with various concentrations of fluorescently labeled IL-23 (IL-23-TAMRA) in the presence or absence of unlabeled IL-23. The NanoLuciferase substrate furimazine was then added (final concentration: 7.7 μM) and emitted luminescence and fluorescence were simultaneously detected with a BMG Pherastar FS. BRET ratios were calculated by subtracting fluorescence from luminescence. The specific binding of IL-23-TAMRA was calculated by subtracting BRET ratios determined in the presence of unlabeled IL-23 (non-specific binding) from those obtained in its absence. The data shown are the mean ± SEM ( n = 4-5 independent experiments performed in triplicate wells for NLuc IL-23R wildtype vs. NLuc IL-23R R381Q; n = 5 independent experiments performed in triplicate for NLuc IL-23R wildtype vs. NLuc IL-23R G300V; n = 5 independent experiments performed in duplicate for NLuc IL-23R wildtype vs. NLuc IL-23R G149R or NLuc IL23R L372F). (D) Representative results for pSTAT3 detection by western blotting after IL-23 stimulation (10 ng/mL) in EBV-B cell lines from healthy donors (HD: green), IL23R R381Q/R381Q (P12, P17, and P4: violet), IL23R G300V/G300V (P18, P19, and 20: orange) and IL23R LOF/LOF ( IL-23R -/- : red) patients. (E) Representative graph of multiple independent western-blot experiments showing pSTAT3/STAT3 band density. If there were several measurements on the same EBV-B cell lines, this is indicated in parentheses. (G) MFI of pSTAT3 normalized against non-stimulated T-blast cells from healthy donors (green dots), IL23R G149R/G149R (yellow dots), IL23R G300V/G300V (orange dots), IL23R R381Q/R381Q (purple dots), IL-12Rβ1- and IL-23R-deficient patients (blue and red dots, respectively) in the presence or absence of various concentrations of IL-23. IFNα2 stimulation (1 ng/mL) was used as a control. Statistical significance was assessed in unpaired Mann-Whitney’s U tests comparing each variant to HD or WT as appropriate. * p < 0.05, ** p <0.01, *** p <0.001, **** p <0.0001.

Journal: bioRxiv

Article Title: Homozygosity for rare or common hypomorphic IL23R variants confers a predisposition to tuberculosis in humans

doi: 10.64898/2026.03.23.713554

Figure Lengend Snippet: (A) Emitted luminescence measured in the presence of the NanoLuc inhibitor is expressed as a percentage of that measured in the absence of the inhibitor (100%), in HEK293T cells transiently transfected with N-terminal NanoLuciferase-tagged versions of the wildtype or variants of the IL-23 receptor (NLuc IL-23R, NLuc IL-23R R381Q, NLuc IL-23R G300V, NLuc IL-23R G149R, NLuc IL-23R L372F or NLuc IL-23R C115Y) and IL-12Rβ1 (4:1 ratio). The data shown are the mean ± SEM from 5-7 independent experiments conducted in triplicate wells. Statistical significance was determined in a paired t-test (*** P <0.001, * P <0.5). Data for NLuc IL-23R C115Y were obtained in a previous study. (B) HEK293T cells transiently transfected as described in A) were imaged with an Olympus LuminoView 200 wide-field luminescence microscope. Representative luminescence images show the signal originating from the N-terminal NLuc tag of each IL-23R variant following the addition of furimazine (final dilution 1:400). Data from three independent experiments are shown. The scale bar represents 50 μm. Luminescence images were acquired with a 60x NA1.42 oil immersion objective, a 0.5x tube lens, and a C9100-23B IMAGE EMX2 camera (Hamamatsu, Japan), with an exposure time of 20 s (gain of 25). (C) HEK293T cells transiently transfected as in A) were treated with various concentrations of fluorescently labeled IL-23 (IL-23-TAMRA) in the presence or absence of unlabeled IL-23. The NanoLuciferase substrate furimazine was then added (final concentration: 7.7 μM) and emitted luminescence and fluorescence were simultaneously detected with a BMG Pherastar FS. BRET ratios were calculated by subtracting fluorescence from luminescence. The specific binding of IL-23-TAMRA was calculated by subtracting BRET ratios determined in the presence of unlabeled IL-23 (non-specific binding) from those obtained in its absence. The data shown are the mean ± SEM ( n = 4-5 independent experiments performed in triplicate wells for NLuc IL-23R wildtype vs. NLuc IL-23R R381Q; n = 5 independent experiments performed in triplicate for NLuc IL-23R wildtype vs. NLuc IL-23R G300V; n = 5 independent experiments performed in duplicate for NLuc IL-23R wildtype vs. NLuc IL-23R G149R or NLuc IL23R L372F). (D) Representative results for pSTAT3 detection by western blotting after IL-23 stimulation (10 ng/mL) in EBV-B cell lines from healthy donors (HD: green), IL23R R381Q/R381Q (P12, P17, and P4: violet), IL23R G300V/G300V (P18, P19, and 20: orange) and IL23R LOF/LOF ( IL-23R -/- : red) patients. (E) Representative graph of multiple independent western-blot experiments showing pSTAT3/STAT3 band density. If there were several measurements on the same EBV-B cell lines, this is indicated in parentheses. (G) MFI of pSTAT3 normalized against non-stimulated T-blast cells from healthy donors (green dots), IL23R G149R/G149R (yellow dots), IL23R G300V/G300V (orange dots), IL23R R381Q/R381Q (purple dots), IL-12Rβ1- and IL-23R-deficient patients (blue and red dots, respectively) in the presence or absence of various concentrations of IL-23. IFNα2 stimulation (1 ng/mL) was used as a control. Statistical significance was assessed in unpaired Mann-Whitney’s U tests comparing each variant to HD or WT as appropriate. * p < 0.05, ** p <0.01, *** p <0.001, **** p <0.0001.

Article Snippet: Plasmids containing the WT human IL23R (Origene #RG211477) ORF were obtained, the tag was removed, and the variants studied here were generated by site-directed mutagenesis with specific primers and CloneAmp HiFi PCR premix (Takara).

Techniques: Transfection, Microscopy, Variant Assay, Labeling, Concentration Assay, Fluorescence, Binding Assay, Western Blot, Control

(A) Dotplot of the expression of lineage- and state-specific marker genes across predicted immune cell types. (B) Heatmap analysis of the GSEA leading-edge genes for the Hallmark IFN-γ response gene set common to IL-23R-deficient and IL-12Rβ1-deficient classic monocytes. Normalized Z -transformed pseudobulk read counts are shown. (C) The fold-change in IFNG mRNA levels following IL-23 stimulation in leukocytes from 3 IL23R R381Q/R381Q , 2 IL23R G300V/G300V , one IL23R G149R/G149R and 2 TYK2 P1104A/P1104A , 1 IL12RB1- /- and 2 IL23R -/- patients was normalized against housekeeping genes across immune cells. Bulk RNA-seq pseudobulk expression counts for IFNG were normalized by this factor to obtain IFNG.HKG values. The delta score is the difference in normalized expression between IL-23 stimulation and non-stimulation (NS) conditions (IL-23 − NS), reflecting the magnitude of gene induction upon stimulation. (D) Two-dimensional plots of IL-23–induced delta IFNG expression. The fold-change difference in IFNG mRNA levels following IL-23 stimulation in leukocytes from IL23R R381Q/R381Q , IL23R G300V/G300V , IL23R G149R/G149R and TYK2 P1104A/P1104A patients relative to controls is shown on the x -axis. The y -axis shows the same parameter for IL23R -/- patients as a comparison. The color of the circles indicates the median fold-change difference (IL-23 versus NS) in normalized IFNG mRNA levels in controls for the corresponding subsets. MAIT, NK, and Vδ2 + γδT cells are highlighted.

Journal: bioRxiv

Article Title: Homozygosity for rare or common hypomorphic IL23R variants confers a predisposition to tuberculosis in humans

doi: 10.64898/2026.03.23.713554

Figure Lengend Snippet: (A) Dotplot of the expression of lineage- and state-specific marker genes across predicted immune cell types. (B) Heatmap analysis of the GSEA leading-edge genes for the Hallmark IFN-γ response gene set common to IL-23R-deficient and IL-12Rβ1-deficient classic monocytes. Normalized Z -transformed pseudobulk read counts are shown. (C) The fold-change in IFNG mRNA levels following IL-23 stimulation in leukocytes from 3 IL23R R381Q/R381Q , 2 IL23R G300V/G300V , one IL23R G149R/G149R and 2 TYK2 P1104A/P1104A , 1 IL12RB1- /- and 2 IL23R -/- patients was normalized against housekeeping genes across immune cells. Bulk RNA-seq pseudobulk expression counts for IFNG were normalized by this factor to obtain IFNG.HKG values. The delta score is the difference in normalized expression between IL-23 stimulation and non-stimulation (NS) conditions (IL-23 − NS), reflecting the magnitude of gene induction upon stimulation. (D) Two-dimensional plots of IL-23–induced delta IFNG expression. The fold-change difference in IFNG mRNA levels following IL-23 stimulation in leukocytes from IL23R R381Q/R381Q , IL23R G300V/G300V , IL23R G149R/G149R and TYK2 P1104A/P1104A patients relative to controls is shown on the x -axis. The y -axis shows the same parameter for IL23R -/- patients as a comparison. The color of the circles indicates the median fold-change difference (IL-23 versus NS) in normalized IFNG mRNA levels in controls for the corresponding subsets. MAIT, NK, and Vδ2 + γδT cells are highlighted.

Article Snippet: Plasmids containing the WT human IL23R (Origene #RG211477) ORF were obtained, the tag was removed, and the variants studied here were generated by site-directed mutagenesis with specific primers and CloneAmp HiFi PCR premix (Takara).

Techniques: Expressing, Marker, Transformation Assay, RNA Sequencing, Comparison